A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study

<p>Abstract</p> <p>Background</p> <p>Computer tomography (CT) is still the fastest and most robust technique to rule out ICH in acute stroke. However CT-sensitivity for detection of ischemic stroke in the hyperacute phase is still relatively low. Moreover the validity o...

Full description

Bibliographic Details
Main Authors: Knauer Carolin, Knauer Katharina, Müller Susanne, Ludolph Albert C, Bengel Dietmar, Müller Hans P, Huber Roman
Format: Article
Language:English
Published: BMC 2012-03-01
Series:BMC Neurology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2377/12/14
id doaj-5c89a45511444e3aa2d52bba7735295d
record_format Article
spelling doaj-5c89a45511444e3aa2d52bba7735295d2020-11-24T20:46:48ZengBMCBMC Neurology1471-23772012-03-011211410.1186/1471-2377-12-14A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective studyKnauer CarolinKnauer KatharinaMüller SusanneLudolph Albert CBengel DietmarMüller Hans PHuber Roman<p>Abstract</p> <p>Background</p> <p>Computer tomography (CT) is still the fastest and most robust technique to rule out ICH in acute stroke. However CT-sensitivity for detection of ischemic stroke in the hyperacute phase is still relatively low. Moreover the validity of pure clinical judgment is diminished by several stroke imitating diseases (mimics). The "Triage<sup>® </sup>Stroke Panel", a biochemical multimarker assay, detects Brain Natriuretic Peptide (BNP), D-Dimers (DD), Matrix-Metalloproteinase-9 (MMP-9), and S100B protein and promptly generates a Multimarkerindex of these values (MMX). This index has been licensed for diagnostic purposes as it might increase the validity of the clinical diagnosis to differentiate between stroke imitating diseases and true ischemic strokes. Our aim was to prove whether the panel is a reliable indicating device for the diagnosis of ischemic stroke in a time window of 6 h to fasten the pre- and intrahospital pathway to fibrinolysis.</p> <p>Methods</p> <p>We investigated all consecutive patients admitted to our stroke unit during a time period of 5 months. Only patients with clinical investigation, blood sample collection and MRI within six hours from symptom onset were included. Values of biochemical markers were analyzed according to the results of diffusion weighted MR-imaging. In addition MMX-values in ischemic strokes were correlated with the TOAST-criteria. For statistical analysis the SAS Analyst software was used. Correlation coefficients were analyzed and comparison tests for two or more groups were performed. Statistical significance was assumed in case of <it>p </it>< 0.05. Finally a ROC-analysis was performed for the MMX-Index.</p> <p>Results</p> <p>In total 174 patients were included into this study (n = 100 strokes, n = 49 mimics, n = 25 transitoric ischemic attacks). In patients with ischemic strokes the mean NIHSS was 7.6 ± 6.2, while the mean DWI-lesion volume was 20.6 ml (range 186.9 to 4.2 ml). According to the MMX or the individual markers there was no statistically significant difference between the group of ischemic strokes and the group of mimics. Moreover the correlation of the index and the DWI-lesion-volume was poor (<it>p </it>= 0.2).</p> <p>Conclusions</p> <p>In our setting of acute MRI-proven ischemic stroke the used multimarker-assay (Triage<sup>® </sup>Stroke Panel) was not of diagnostic validity. We do not recommend to perform this assay as this might lead to a unjustified time delay.</p> http://www.biomedcentral.com/1471-2377/12/14StrokeBiochemical markerBrain natriuretic peptideD-dimersMatrix-metalloproteinase-9
collection DOAJ
language English
format Article
sources DOAJ
author Knauer Carolin
Knauer Katharina
Müller Susanne
Ludolph Albert C
Bengel Dietmar
Müller Hans P
Huber Roman
spellingShingle Knauer Carolin
Knauer Katharina
Müller Susanne
Ludolph Albert C
Bengel Dietmar
Müller Hans P
Huber Roman
A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
BMC Neurology
Stroke
Biochemical marker
Brain natriuretic peptide
D-dimers
Matrix-metalloproteinase-9
author_facet Knauer Carolin
Knauer Katharina
Müller Susanne
Ludolph Albert C
Bengel Dietmar
Müller Hans P
Huber Roman
author_sort Knauer Carolin
title A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
title_short A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
title_full A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
title_fullStr A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
title_full_unstemmed A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study
title_sort biochemical marker panel in mri-proven hyperacute ischemic stroke-a prospective study
publisher BMC
series BMC Neurology
issn 1471-2377
publishDate 2012-03-01
description <p>Abstract</p> <p>Background</p> <p>Computer tomography (CT) is still the fastest and most robust technique to rule out ICH in acute stroke. However CT-sensitivity for detection of ischemic stroke in the hyperacute phase is still relatively low. Moreover the validity of pure clinical judgment is diminished by several stroke imitating diseases (mimics). The "Triage<sup>® </sup>Stroke Panel", a biochemical multimarker assay, detects Brain Natriuretic Peptide (BNP), D-Dimers (DD), Matrix-Metalloproteinase-9 (MMP-9), and S100B protein and promptly generates a Multimarkerindex of these values (MMX). This index has been licensed for diagnostic purposes as it might increase the validity of the clinical diagnosis to differentiate between stroke imitating diseases and true ischemic strokes. Our aim was to prove whether the panel is a reliable indicating device for the diagnosis of ischemic stroke in a time window of 6 h to fasten the pre- and intrahospital pathway to fibrinolysis.</p> <p>Methods</p> <p>We investigated all consecutive patients admitted to our stroke unit during a time period of 5 months. Only patients with clinical investigation, blood sample collection and MRI within six hours from symptom onset were included. Values of biochemical markers were analyzed according to the results of diffusion weighted MR-imaging. In addition MMX-values in ischemic strokes were correlated with the TOAST-criteria. For statistical analysis the SAS Analyst software was used. Correlation coefficients were analyzed and comparison tests for two or more groups were performed. Statistical significance was assumed in case of <it>p </it>< 0.05. Finally a ROC-analysis was performed for the MMX-Index.</p> <p>Results</p> <p>In total 174 patients were included into this study (n = 100 strokes, n = 49 mimics, n = 25 transitoric ischemic attacks). In patients with ischemic strokes the mean NIHSS was 7.6 ± 6.2, while the mean DWI-lesion volume was 20.6 ml (range 186.9 to 4.2 ml). According to the MMX or the individual markers there was no statistically significant difference between the group of ischemic strokes and the group of mimics. Moreover the correlation of the index and the DWI-lesion-volume was poor (<it>p </it>= 0.2).</p> <p>Conclusions</p> <p>In our setting of acute MRI-proven ischemic stroke the used multimarker-assay (Triage<sup>® </sup>Stroke Panel) was not of diagnostic validity. We do not recommend to perform this assay as this might lead to a unjustified time delay.</p>
topic Stroke
Biochemical marker
Brain natriuretic peptide
D-dimers
Matrix-metalloproteinase-9
url http://www.biomedcentral.com/1471-2377/12/14
work_keys_str_mv AT knauercarolin abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT knauerkatharina abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT mullersusanne abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT ludolphalbertc abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT bengeldietmar abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT mullerhansp abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT huberroman abiochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT knauercarolin biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT knauerkatharina biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT mullersusanne biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT ludolphalbertc biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT bengeldietmar biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT mullerhansp biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
AT huberroman biochemicalmarkerpanelinmriprovenhyperacuteischemicstrokeaprospectivestudy
_version_ 1716811485331587072